Study of Immunomodulation Using Naltrexone and Ketamine for COVID-19

Clinical trial NCT04365985 · TERMINATED

Trial details

NCT number: NCT04365985
Sponsor: Corewell Health East
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

COVID-19 Acute Respiratory Distress Syndrome Severe Acute Respiratory Syndrome (SARS)Coronavirus Infections

Start date: 2020-04-29
Primary completion: 2021-04-01
Enrollment: 70

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.